NASDAQ · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · SMALL CAP
Charming Medical Ltd. MCTA
3 fiscal years on record · USD · FY2025 reported · SEC filings only
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
USD 4.8M
Revenue, FY2025 · full 3-year series below
Revenue $M
Net income $M
FY2025 · Revenue 4.8 · Net income -0.0
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−0 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -0.6% · Net -0.5%
ROE
Not applicable: equity was zero or negative in this period, so return on equity has no meaning.
Three returns, three denominators.
Each USD of equity lost 1 cents this year.
The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | 0.0 | 0.0 |
| EBITDA $B | 0.0 | 0.0 | 0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | 0.0 | 0.0 |
| Free cash flow $B | −0.0 | 0.0 | 0.0 |
| EPS, diluted $ | 0.00 | 0.08 | 0.05 |
| Dividend / sh $ | · | · | · |
| Payout % | · | · | · |
| ROE % | −0.9 | · | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 9 reconciliationsAUDITED
Reconciled in 3 of 19 fiscal years. 34 checks were skipped: the balance sheet is not tagged before 2024. 16 checks were skipped: EPS is not tagged before 2023. 16 checks were skipped: revenue is not tagged before 2023.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Misc Health & Allied Services, NEC
Listed onNASDAQ
Incorporated innot stated in the filings
Fiscal year endsnot stated in the filings
SEC categoryemerging growth company
Data on record since2023